Insider trading

Period: 120 months Stock: AUPH Minimum amount: $1M × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

29 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

29 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

29 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

29 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
29 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
29 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

29 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
2 Jun 2026
TANG KEVIN Chief Executive Officer · indirect
Bought
$3.15M 206,005 at 15.28
1.6%
1 Jun 2026
TANG KEVIN Chief Executive Officer · indirect
Bought 2×
$5.25M 343,620 at 15.28
2.8%
29 May 2026
TANG KEVIN Chief Executive Officer · indirect
Bought 2×
$4.06M 264,981 at 15.31
2.2%
3 Mar 2026
TANG KEVIN Director · indirect
Bought
$2.62M 184,208 at 14.22
1.5%
2 Mar 2026
TANG KEVIN Director · indirect
Bought 2×
$2.84M 199,353 at 14.26
1.7%
27 Feb 2026
TANG KEVIN Director · indirect
Bought 3×
$7.23M 516,439 at 13.99
4.6%
5 Aug 2025
TANG KEVIN Director · indirect
Bought
$2.34M 200,000 at 11.68
1.8%
4 Aug 2025
TANG KEVIN Director · indirect
Bought
$1.13M 100,000 at 11.34
0.9%
1 Aug 2025
TANG KEVIN Director · indirect
Bought
$10.12M 1,000,000 at 10.12
10.0%
Largest buy in 3 yrs
4 Mar 2025
TANG KEVIN Director · indirect
Bought 3×
$5.95M 748,038 at 7.96
8.1%
Largest buy in 3 yrs
4 Mar 2025
Greenleaf Peter Chief Executive Officer
Sold at will
$1.31M 164,947 at 7.92
8.4%
Not planned
3 Mar 2025
TANG KEVIN Director · indirect
Bought 2×
$3.63M 452,682 at 8.01
5.1%
3 Mar 2025
Greenleaf Peter Chief Executive Officer
Sold at will
$1.56M 195,593 at 8.00
9.1%
Not planned
28 Feb 2025
TANG KEVIN Director · indirect
Bought
$3.13M 399,280 at 7.85
4.7%
9 Dec 2024
TANG KEVIN Director · indirect
Bought
$4.55M 500,000 at 9.09
6.3%
Largest buy in 3 yrs
6 Dec 2024
TANG KEVIN Director · indirect
Bought
$3.60M 400,000 at 9.01
5.3%
Largest buy in 3 yrs
5 Dec 2024
TANG KEVIN Director · indirect
Bought
$2.67M 300,000 at 8.91
4.1%
First buy on file
11 Nov 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated
$2.89M 100,000 at 28.89
53.4%
Sold half or more
11 Nov 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated 2×
$1.16M 40,000 at 29.01
41.7%
10 Nov 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated 2×
$3.11M 100,000 at 31.11
53.4%
Sold half or more
10 Nov 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated 2×
$1.87M 60,000 at 31.14
47.3%
9 Nov 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated
$1.51M 50,000 at 30.17
36.4%
9 Nov 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$1.51M 50,000 at 30.17
28.3%
1 Nov 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$1.42M 45,000 at 31.64
20.3%
1 Nov 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated
$1.42M 45,000 at 31.64
24.7%
25 Oct 2021
Huizinga Robert Bindert EVP of Research
Sold, plan not stated
$3.87M 130,000 at 29.75
66.4%
Sold half or more
21 Sep 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$2.10M 87,500 at 24.02
33.1%
14 Sep 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated 3×
$2.87M 134,000 at 21.38
43.1%
10 Sep 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated
$2.98M 150,000 at 19.84
52.2%
Sold half or more
Showing 1–29 of 29.